FOXM1 and breast carcinoma: In this study, we observed that inhibition of FOXM1 activity by these compounds led to decreased breast cancer cell migratory and invasiveness properties, and that this was associated with the suppression of key factors involved in the EMT process as well as other FOXM1 target genes associated with tumor progression.